These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19541577)

  • 1. Biliary diseases in heart transplanted patients: a comparison between cyclosporine A versus tacrolimus-based immunosuppression.
    Stief J; Stempfle HU; Götzberger M; Uberfuhr P; Köpple M; Lehnert P; Kaiser C; Schiemann U
    Eur J Med Res; 2009 May; 14(5):206-9. PubMed ID: 19541577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of malignant neoplasia after heart transplantation--a comparison between cyclosporine a and tacrolimus.
    Fuchs U; Klein S; Zittermann A; Ensminger SM; Schulz U; Gummert JF
    Ann Transplant; 2014 Jun; 19():300-4. PubMed ID: 24953848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advantageous effects of immunosuppression with tacrolimus in comparison with cyclosporine A regarding renal function in patients after heart transplantation.
    Helmschrott M; Rivinius R; Ruhparwar A; Schmack B; Erbel C; Gleissner CA; Akhavanpoor M; Frankenstein L; Ehlermann P; Bruckner T; Katus HA; Doesch AO
    Drug Des Devel Ther; 2015; 9():1217-24. PubMed ID: 25759566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of cholecystolithiasis and its management among kidney/pancreas-transplanted type 1 (insulin-dependent) diabetic patients.
    Schiemann U; Ferhat A; Götzberger M; Kaiser C; Stief J; Landgraf R; Dieterle C
    Eur J Med Res; 2008 Mar; 13(3):127-30. PubMed ID: 18499558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus.
    Taylor DO; Barr ML; Radovancevic B; Renlund DG; Mentzer RM; Smart FW; Tolman DE; Frazier OH; Young JB; VanVeldhuisen P
    J Heart Lung Transplant; 1999 Apr; 18(4):336-45. PubMed ID: 10226898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients.
    Sommerer C; Suwelack B; Dragun D; Schenker P; Hauser IA; Witzke O; Hugo C; Kamar N; Merville P; Junge M; Thaiss F; Nashan B;
    Kidney Int; 2019 Jul; 96(1):231-244. PubMed ID: 31027892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of development of obesity after heart transplantation according to the calcineurin inhibitor.
    López-Vilella R; Sánchez-Lázaro IJ; Martínez-Dolz L; Almenar-Bonet L; Marqués-Sulé E; Melero-Ferrer J; Portolés-Sanz M; Rivera-Otero M; Domingo-Valero D; Montero-Argudo A
    Transplant Proc; 2015; 47(1):127-9. PubMed ID: 25645789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral health in liver transplant children administered cyclosporin A or tacrolimus.
    Wondimu B; Németh A; Modéer T
    Int J Paediatr Dent; 2001 Nov; 11(6):424-9. PubMed ID: 11759102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New onset dyslipidemia after renal transplantation: is there a difference between tacrolimus and cyclosporine?
    Deleuze S; Garrigue V; Delmas S; Chong G; Swarcz I; Cristol JP; Mourad G
    Transplant Proc; 2006 Sep; 38(7):2311-3. PubMed ID: 16980075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin Resistance in Nonobese Renal Allograft Recipients on Maintenance Doses of Cyclosporine or Tacrolimus.
    Soypacaci Z; Akgun AO; Sengul S; Keven K
    Transplant Proc; 2019 Sep; 51(7):2339-2342. PubMed ID: 31402251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of type of calcineurin inhibitor on post-transplant tuberculosis: Single-center study from India.
    Agarwal SK; Bhowmik D; Mahajan S; Bagchi S
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27775825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching from cyclosporine to tacrolimus in patients with chronic transplant dysfunction or cyclosporine-induced adverse events.
    Cantarovich D; Renou M; Megnigbeto A; Giral-Classe M; Hourmant M; Dantal J; Blancho G; Karam G; Soulillou JP
    Transplantation; 2005 Jan; 79(1):72-8. PubMed ID: 15714172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome in heart transplant recipients receiving everolimus in combination with dosage reduction of the calcineurin inhibitor cyclosporine A or tacrolimus.
    Fuchs U; Zittermann A; Ensminger SM; Schulz U; Gummert JF
    Transpl Immunol; 2014 Aug; 31(2):87-91. PubMed ID: 24932812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients.
    Charpentier B; Rostaing L; Berthoux F; Lang P; Civati G; Touraine JL; Squifflet JP; Vialtel P; Abramowicz D; Mourad G; Wolf P; Cassuto E; Moulin B; Rifle G; Pruna A; Merville P; Mignon F; Legendre C; Le Pogamp P; Lebranchu Y; Toupance O; Hurault De Ligny B; Touchard G; Olmer M; Purgus R; Pouteil-Noble C; Glotz D; Bourbigot B; Leski M; Wauters JP; Kessler M
    Transplantation; 2003 Mar; 75(6):844-51. PubMed ID: 12660513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus.
    Stegall MD; Wachs ME; Everson G; Steinberg T; Bilir B; Shrestha R; Karrer F; Kam I
    Transplantation; 1997 Dec; 64(12):1755-60. PubMed ID: 9422416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary immunosuppression and outcome differences after heart transplantation: tacrolimus versus cyclosporine.
    Castel MA; Farrero M; Vallejos I; Cardona M; Regueiro A; Pérez-Villa F
    Transplant Proc; 2011; 43(6):2244-6. PubMed ID: 21839245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal Function Changes Under Everolimus Plus Cyclosporine or Everolimus Plus Tacrolimus After Heart Transplantation.
    Chiang TY; Tsao CI; Wang SS
    Transplant Proc; 2018 Nov; 50(9):2756-2758. PubMed ID: 30401391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New-Onset Diabetes After Transplantation: Comparison Between a Cyclosporine-Based and a Tacrolimus-Based Immunosuppressive Regimen.
    Zolota A; Miserlis G; Solonaki F; Tranda A; Antoniadis N; Imvrios G; Fouzas I
    Transplant Proc; 2018 Dec; 50(10):3386-3391. PubMed ID: 30577210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection rates in tacrolimus versus cyclosporine-treated pediatric kidney transplant recipients on a rapid discontinuation of prednisone protocol: 1-year analysis.
    Kizilbash SJ; Rheault MN; Bangdiwala A; Matas A; Chinnakotla S; Chavers BM
    Pediatr Transplant; 2017 Jun; 21(4):. PubMed ID: 28371243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.